To understand key trends
Download Free Sample
The insecticides segment is projected to dominate the global 2,5-dimethyl-2,4-hexadiene market and shall account demand share of more than 60% in 2027 owing to the rising usage of insecticides in the agricultural and industrial sectors. The growing need for food, especially in the Asia Pacific region, and rising awareness on the usage of low-toxic insecticides in arable lands are expected to drive product demand.
Additionally, the growing production of corn, cotton, and soybean in the U.S. is likely to boost pesticide demand, thereby, propelling the adoption of 2,5-dimethyl-2,4-hexadiene. Furthermore, the ongoing pandemic is expected to rise domestic hygiene trends amongst people further rising the demand for insecticides across the globe.
The production of 9-chloroanthracene is expected to showcase the highest growth rate and shall exceed revenue generation of USD 65 thousand by 2027 owing to the rising usage of 9-chloroanthracene as an intermediate in several pharmaceutical applications. 9-chloroanthracene also shows good anticancer activity. For instance, in 2018, the in-vitro anticancer activity of 9-chloroanthracene was screened against three human cancer cell lines, MCF-7 (Breast), HepG (Liver), and IMR-32 (neuroblastoma) using the MTT assay. The trends will thus drive the global 2,5-dimethyl-2,4-hexadiene market share.
To understand key market trends
Download Free Sample
Asia Pacific is expected dominated the global 2,5-dimethyl-2,4-hexadiene market and accounted for over 45% demand share in 2020 owing to the growing demand for insecticides coupled with the rising concern to develop low-toxic insecticides. The rapidly growing population in countries including China and India is the major factor driving the need for food which, in turn, is boosting the adoption of insecticides, thereby, propelling the consumption of 2,5-dimethyl-2,4-hexadiene in the production of insecticides.
North America is projected to grow at 2.7% CAGR owing to the rising application of the product in research laboratories for biochemical reactions. Additionally, the rapid surge in cancer patients in the U.S. is likely to increase the adoption of 2,5-dimethyl-2,4-hexadiene for the development of biomarkers for lung cancer treatment. Therefore, these trends are anticipated to drive the global 2,5-dimethyl-2,4-hexadiene market growth in the coming years.